• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定性方法如何用于指导模型开发。

How Qualitative Methods Can be Used to Inform Model Development.

作者信息

Husbands Samantha, Jowett Susan, Barton Pelham, Coast Joanna

机构信息

School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.

Health Economics Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

出版信息

Pharmacoeconomics. 2017 Jun;35(6):607-612. doi: 10.1007/s40273-017-0499-z.

DOI:10.1007/s40273-017-0499-z
PMID:28321640
Abstract

Decision-analytic models play a key role in informing healthcare resource allocation decisions. However, there are ongoing concerns with the credibility of models. Modelling methods guidance can encourage good practice within model development, but its value is dependent on its ability to address the areas that modellers find most challenging. Further, it is important that modelling methods and related guidance are continually updated in light of any new approaches that could potentially enhance model credibility. The objective of this article was to highlight the ways in which qualitative methods have been used and recommended to inform decision-analytic model development and enhance modelling practices. With reference to the literature, the article discusses two key ways in which qualitative methods can be, and have been, applied. The first approach involves using qualitative methods to understand and inform general and future processes of model development, and the second, using qualitative techniques to directly inform the development of individual models. The literature suggests that qualitative methods can improve the validity and credibility of modelling processes by providing a means to understand existing modelling approaches that identifies where problems are occurring and further guidance is needed. It can also be applied within model development to facilitate the input of experts to structural development. We recommend that current and future model development would benefit from the greater integration of qualitative methods, specifically by studying 'real' modelling processes, and by developing recommendations around how qualitative methods can be adopted within everyday modelling practice.

摘要

决策分析模型在为医疗资源分配决策提供信息方面发挥着关键作用。然而,人们对模型的可信度一直存在担忧。建模方法指南可以鼓励模型开发中的良好实践,但其价值取决于它解决建模人员认为最具挑战性领域的能力。此外,重要的是,建模方法和相关指南应根据任何可能提高模型可信度的新方法不断更新。本文的目的是强调定性方法在为决策分析模型开发提供信息和加强建模实践方面的使用方式和建议。参考相关文献,本文讨论了定性方法可以且已经被应用的两种关键方式。第一种方法是使用定性方法来理解和为模型开发的一般及未来过程提供信息,第二种方法是使用定性技术直接为单个模型的开发提供信息。文献表明,定性方法可以通过提供一种理解现有建模方法的手段来提高建模过程的有效性和可信度,这种手段能够识别问题所在以及何处需要进一步指导。它还可以应用于模型开发过程中,以促进专家对结构开发的投入。我们建议,当前和未来的模型开发将受益于定性方法的更大程度整合,特别是通过研究“实际”建模过程,以及围绕如何在日常建模实践中采用定性方法制定建议。

相似文献

1
How Qualitative Methods Can be Used to Inform Model Development.定性方法如何用于指导模型开发。
Pharmacoeconomics. 2017 Jun;35(6):607-612. doi: 10.1007/s40273-017-0499-z.
2
Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study.理解和识别临床医生参与决策分析模型结构制定中的关键问题:一项定性研究。
Pharmacoeconomics. 2018 Dec;36(12):1453-1462. doi: 10.1007/s40273-018-0705-7.
3
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.
4
Recent developments in decision-analytic modelling for economic evaluation.用于经济评估的决策分析模型的最新进展。
Pharmacoeconomics. 2006;24(11):1043-53. doi: 10.2165/00019053-200624110-00002.
5
Sustainability in Health care by Allocating Resources Effectively (SHARE) 11: reporting outcomes of an evidence-driven approach to disinvestment in a local healthcare setting.通过有效分配资源实现医疗保健可持续性(SHARE)11:报告在当地医疗环境中以循证方法进行撤资的结果。
BMC Health Serv Res. 2018 May 30;18(1):386. doi: 10.1186/s12913-018-3172-0.
6
Recommendations for increasing the use of HIV/AIDS resource allocation models.提高 HIV/AIDS 资源分配模型使用的建议。
BMC Public Health. 2009 Nov 18;9 Suppl 1(Suppl 1):S8. doi: 10.1186/1471-2458-9-S1-S8.
7
Analytic approaches for research priority-setting: issues, challenges and the way forward.研究重点确定的分析方法:问题、挑战及未来方向。
Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):745-54. doi: 10.1586/14737167.2015.1087317.
8
Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?“标准博弈”和“时间权衡”效用测量是否应在心理健康研究中得到更多应用?
J Ment Health Policy Econ. 2010 Jun;13(2):65-72.
9
The value of models in informing resource allocation in colorectal cancer screening: the case of The Netherlands.模型在为结直肠癌筛查资源分配提供信息方面的价值:以荷兰为例。
Gut. 2015 Dec;64(12):1985-97. doi: 10.1136/gutjnl-2015-309316. Epub 2015 Jun 10.
10
Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.基于母婴模拟学习的学生和教育工作者体验:定性证据协议的系统评价
JBI Database System Rev Implement Rep. 2015 Jan;13(1):14-26. doi: 10.11124/jbisrir-2015-1694.

引用本文的文献

1
Co-designing a Structured Expert Elicitation with Clinicians to Enhance Health Care Decision Making in Exercise Oncology.与临床医生共同设计结构化专家意见征集,以加强运动肿瘤学中的医疗保健决策。
Med Decis Making. 2025 Jul;45(5):602-613. doi: 10.1177/0272989X251332967. Epub 2025 Apr 25.
2
Beyond clinical and cost-effectiveness: The contribution of qualitative research to health technology assessment.超越临床和成本效益:定性研究对健康技术评估的贡献。
Int J Technol Assess Health Care. 2023 Apr 24;39(1):e23. doi: 10.1017/S0266462323000211.
3
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease.

本文引用的文献

1
A Framework for Developing the Structure of Public Health Economic Models.构建公共卫生经济模型结构的框架
Value Health. 2016 Jul-Aug;19(5):588-601. doi: 10.1016/j.jval.2016.02.011. Epub 2016 Apr 23.
2
Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.基于模型的经济评估中专家判断使用的报告指南。
Pharmacoeconomics. 2016 Nov;34(11):1161-1172. doi: 10.1007/s40273-016-0425-9.
3
The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling.被忽视的利益相关者群体:患者为何应参与卫生经济建模
评估用于治疗镰状细胞病的新非治愈性和治愈性疗法的概念模型的制定。
PLoS One. 2022 Apr 28;17(4):e0267448. doi: 10.1371/journal.pone.0267448. eCollection 2022.
4
Health state utilities for beta-thalassemia: a time trade-off study.β-地中海贫血的健康状态效用:时间权衡研究。
Eur J Health Econ. 2023 Feb;24(1):27-38. doi: 10.1007/s10198-022-01449-7. Epub 2022 Mar 26.
5
Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine.量化经济评估中容量限制的影响:精准医学的应用。
Med Decis Making. 2022 May;42(4):538-553. doi: 10.1177/0272989X211053792. Epub 2021 Oct 25.
6
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values.复发/难治性淋巴肿瘤的基因组检测:了解患者价值观。
Patient. 2021 Mar;14(2):187-196. doi: 10.1007/s40271-020-00448-1.
7
Structuring a conceptual model for cost-effectiveness analysis of frailty interventions.构建衰弱干预措施成本效益分析的概念模型。
PLoS One. 2019 Sep 11;14(9):e0222049. doi: 10.1371/journal.pone.0222049. eCollection 2019.
8
Health State Utilities for Acute Myeloid Leukaemia: A Time Trade-off Study.急性髓系白血病的健康状态效用值:时间权衡研究。
Pharmacoeconomics. 2019 Jan;37(1):85-92. doi: 10.1007/s40273-018-0704-8.
9
Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study.理解和识别临床医生参与决策分析模型结构制定中的关键问题:一项定性研究。
Pharmacoeconomics. 2018 Dec;36(12):1453-1462. doi: 10.1007/s40273-018-0705-7.
10
Model Structuring for Economic Evaluations of New Health Technologies.新型卫生技术经济评估的模型构建。
Pharmacoeconomics. 2018 Nov;36(11):1309-1319. doi: 10.1007/s40273-018-0693-7.
Appl Health Econ Health Policy. 2016 Apr;14(2):129-33. doi: 10.1007/s40258-015-0200-7.
4
A Systematic Review of Research Guidelines in Decision-Analytic Modeling.决策分析模型中研究指南的系统评价
Value Health. 2015 Jun;18(4):512-29. doi: 10.1016/j.jval.2014.12.014. Epub 2015 Feb 7.
5
Identification and review of cost-effectiveness model parameters: a qualitative study.成本效益模型参数的识别与综述:一项定性研究。
Int J Technol Assess Health Care. 2014 Jul;30(3):333-40. doi: 10.1017/S0266462314000245. Epub 2014 Aug 4.
6
Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments.回顾证据,为卫生技术评估中的成本效益模型提供信息。
Value Health. 2013 Jul-Aug;16(5):830-6. doi: 10.1016/j.jval.2013.04.009. Epub 2013 Jun 19.
7
More than figures? Qualitative research in health economics.不止于数字?卫生经济学中的定性研究。
Health Econ. 2013 Mar;22(3):253-7. doi: 10.1002/hec.2906.
8
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.概念化模型:ISPOR-SMDM 建模良好研究实践工作组的报告--2.
Value Health. 2012 Sep-Oct;15(6):804-11. doi: 10.1016/j.jval.2012.06.016.
9
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.模型化良好的研究实践概述:ISPOR-SMDM 模型化良好的研究实践工作组的报告——1.
Value Health. 2012 Sep-Oct;15(6):796-803. doi: 10.1016/j.jval.2012.06.012.
10
A qualitative study of manufacturers' submissions to the UK NICE single technology appraisal process.对制造商提交给英国国家卫生与临床优化研究所单一技术评估流程的材料进行的定性研究。
BMJ Open. 2012 Feb 8;2(1):e000562. doi: 10.1136/bmjopen-2011-000562. Print 2012.